Inventor
MCKITTRICK BRIAN A
US35 patents
⚠️ This page may combine multiple inventors who share the name “MCKITTRICK BRIAN A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
22 patentsUSRE37721EMay 28, 2002
Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
SCHERING CORP99 citations99
US5846966ADec 8, 1998
Combinations of hydroxy-substituted azetidinone compounds and HMG CoA Reductase Inhibitors
SCHERING CORP171 citations99
US6689765B2Feb 10, 2004
Piperazine derivatives useful as CCR5 antagonists
SCHERING CORP71 citations97
US6391865B1May 21, 2002
Piperazine derivatives useful as CCR5 antagonists
SCHERING CORP94 citations97
US6387930B1May 14, 2002
Piperidine derivatives useful as CCR5 antagonists
SCHERING CORP76 citations96
US5824683AOct 20, 1998
2'- 4'-halo- 1,1'-biphenyl!-4-yl!methyl!-5'-methyl-spiro cyclopentane-1,7' (8'H)- 3H! imidazo 2,1-b!purin!-4' (5'H)-ones
SCHERING CORP70 citations96
US5744467AApr 28, 1998
Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
SCHERING CORP77 citations96
US5633246AMay 27, 1997
Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
SCHERING CORP91 citations96
US5624920AApr 29, 1997
Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
SCHERING CORP88 citations96
US6602885B2Aug 5, 2003
Piperidine derivatives useful as CCR5 antagonists
SCHERING CORP21 citations92
US5476847ADec 19, 1995
Derivatives of phosphinic acid useful as endothelin converting enzyme inhibitors
SCHERING CORP25 citations92
US6458812B1Oct 1, 2002
Muscarinic antagonists
SCHERING CORP56 citations91
US7700601B2Apr 20, 2010
Substituted indazoles of formula 1.0 that are kinase inhibitors
SCHERING CORP38 citations90
US6472394B1Oct 29, 2002
MCH antagonists and their use in the treatment of obesity
SCHERING CORP24 citations89
USRE42461EJun 14, 2011
Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
SCHERING CORP7 citations84
US7700603B2Apr 20, 2010
Heterocyclic aspartyl protease inhibitors
SCHERING CORP9 citations84
US7528132B2May 5, 2009
Kinase inhibitors
SCHERING CORP14 citations83
US7638526B2Dec 29, 2009
Azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism
SCHERING CORP8 citations82
US7384944B2Jun 10, 2008
Piperazine derivatives useful as CCR5 antagonists
SCHERING CORP6 citations73
US7723342B2May 25, 2010
Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
SCHERING CORP4 citations63
US7902157B2Mar 8, 2011
Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism
SCHERING CORP1 citations52
US7361769B2Apr 22, 2008
Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
SCHERING CORP0 citations41
SCHERING PLOUGH CORP
3 patentsUS5767115AJun 16, 1998
Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
SCHERING PLOUGH CORP267 citations99
US5939419AAug 17, 1999
2-benzyl-polycyclic guanine derivatives and process for preparing them
SCHERING PLOUGH CORP83 citations96
US7884080B2Feb 8, 2011
Azetidinone derivatives and methods of use thereof
SCHERING PLOUGH CORP46 citations93
AMERICAN HOME PROD
3 patentsUS4785015ANov 15, 1988
Substituted 1,3,4,9-tetrahydropyrano [3,4-B]indole-1-acetic acids
AMERICAN HOME PROD5 citations73
US4904799AFeb 27, 1990
Preparation of tryptophols
AMERICAN HOME PROD0 citations51
US4886886ADec 12, 1989
Substituted 1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acids
AMERICAN HOME PROD1 citations51